HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of Sirtuin 3, a mitochondrial protein deacetylase, as a new contributor to tamoxifen resistance in breast cancer cells.

Abstract
The current study reports a previously unappreciated role of Sirtuin 3 (SIRT3), a mitochondrial protein deacetylase, in altering sensitivity of breast cancer cells to tamoxifen (Tam), a commonly used anti-estrogen agent. We showed that SIRT3 was significantly up-regulated at both mRNA and protein levels in the Tam-resistance human breast cancer cell line MTR-3, which was derived from MCF-7 line by continuous selective culture in the presence of 1μM of Tam for two years. We further demonstrated that SIRT3 was rapidly up-regulated in the sensitive MCF-7 cells following exposure to Tam. Transfection of MCF-7 cells with a SIRT3 expression plasmid decreased cellular sensitivity to Tam and blocked the Tam-induced apoptosis. Furthermore, silencing of SIRT3 expression in MTR-3 cells sensitized the resistant cells to Tam and enhanced apoptotic cell death. MTR-3 cells with silencing of SIRT3 expression showed increases in the mitochondrial content of ERβ, ROS level and apoptosis. These results not only uncovered a new role for SIRT3 in cancer but also identified this mitochondrial protein deacetylase as a previously unrecognized factor that participates in regulation of Tam sensitivity in breast cancer cells. Thus, SIRT3 might be considered as a potential target for overcoming Tam resistance in treatment of breast cancer.
AuthorsLi Zhang, Xingcong Ren, Yan Cheng, Kathryn Huber-Keener, Xiuping Liu, Yi Zhang, Yun-Sheng Yuan, Jay W Yang, Chang-Gong Liu, Jin-Ming Yang
JournalBiochemical pharmacology (Biochem Pharmacol) Vol. 86 Issue 6 Pg. 726-33 (Sep 15 2013) ISSN: 1873-2968 [Electronic] England
PMID23856293 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Chemical References
  • Antineoplastic Agents, Hormonal
  • Estrogen Receptor beta
  • RNA, Small Interfering
  • Reactive Oxygen Species
  • Tamoxifen
  • SIRT3 protein, human
  • Sirtuin 3
Topics
  • Antineoplastic Agents, Hormonal (pharmacology)
  • Apoptosis (genetics)
  • Breast Neoplasms (drug therapy, enzymology, genetics, pathology)
  • Cell Line, Tumor
  • Drug Resistance, Neoplasm (drug effects, genetics)
  • Estrogen Receptor beta (genetics, metabolism)
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mitochondria (drug effects, enzymology, genetics)
  • RNA, Small Interfering (genetics, metabolism)
  • Reactive Oxygen Species (metabolism)
  • Signal Transduction
  • Sirtuin 3 (antagonists & inhibitors, genetics, metabolism)
  • Tamoxifen (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: